ANAVEX LIFE SCIENCES CORP. — Director's Dealing 2021

Jul 2, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ANAVEX LIFE SCIENCES CORP. (AVXL)
CIK: 0001314052
Period of Report: 2021-06-29

Reporting Person: MISSLING CHRISTOPHER U (Director, President and CEO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-06-29	Common Stock	M	51620	$1.32	Acquired	1069830	Direct
2021-06-29	Common Stock	S	51620	$26.00	Disposed	1018210	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-06-29	Stock Option (Right to Buy)	$1.32	M	51620	Disposed	2024-05-08	Common Stock (51620)	Direct

Footnotes

F1: The options subject to this grant vested over 4 years on May 8, 2015, May 8, 2016, May 8, 2017, May 8, 2018.